The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
BioCryst Pharma
BCRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.85
0.3
3.97%
At Close: -
$7.87
0.02
0.25%
After Hours: 6:27 PM EDT
15 minutes delayed
Get Report
Comment
Q2 2024 Earnings in 9 days from now on Mon Aug 5th, before the market open
BioCryst Pharma (BCRX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for BioCryst Pharma (NASDAQ:BCRX) Stock
BioCryst Pharma Stock (NASDAQ: BCRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Sunday, June 02, 2024
BioCryst Announced Data Showing Reductions In Attack Rates In HAE Patients with Normal C1-Inhibitor After Beginning ORLADEYO Treatment
Charles Gross
Wednesday, May 15, 2024
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
BioCryst Pharmaceuticals Form 4 Filings Shows...
Benzinga Newsdesk
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Thursday, May 09, 2024
BioCryst Presents New Real-world Evidence Sho...
Benzinga Newsdesk
Tuesday, May 07, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on BioCrys...
Benzinga Newsdesk
Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk
Monday, May 06, 2024
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
Vandana Singh
BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates
Zacks
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
BioCryst Pharma shares are trading higher fol...
Benzinga Newsdesk
Biocryst Forecasts 2024 Orladeyo Revenue Of $...
Benzinga Newsdesk
BioCryst Pharma Q1 2024 Adj EPS $(0.17) Beats...
Benzinga Newsdesk
Wednesday, April 17, 2024
BioCryst Pharmaceuticals Announced That The B...
Benzinga Newsdesk
Wednesday, April 10, 2024
Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk
Monday, February 26, 2024
What's Going On With BioCryst Stock After Earnings?
Erica Kollmann
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Avi Kapoor
BioCryst Forecasts Fiscal Year 2024 Orladeyo ...
Benzinga Newsdesk
BioCryst Pharma Q4 Adjusted EPS $(0.28) Misse...
Benzinga Newsdesk
Earnings Scheduled For February 26, 2024
Benzinga Insights
Friday, February 23, 2024
A Preview Of BioCryst Pharma's Earnings
Benzinga Insights
BioCryst Pharmaceuticals Says New Analyses Of...
Benzinga Newsdesk
Tuesday, February 20, 2024
Reported Monday, BioCryst Launches ORLADEYO® ...
Benzinga Newsdesk
Monday, January 08, 2024
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
BioCryst Pharmaceuticals shares are trading h...
Benzinga Newsdesk
What's Going On With BioCryst Pharmaceuticals Stock?
Erica Kollmann
Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk
Friday, January 05, 2024
BioCryst Pharmaceuticals Sees FY24 ORLADEYO R...
Benzinga Newsdesk
Biocryst Pharmaceuticals Inc Does Not Intend ...
Benzinga Newsdesk
BioCryst Announces Sees Prelim. Q4 ORLADEYO R...
Benzinga Newsdesk
BioCryst Announces Sees Prelim. FY23 ORLADEYO...
Benzinga Newsdesk
Tuesday, December 19, 2023
BioCryst Pharmaceuticals Says Data From Open-...
Benzinga Newsdesk
Wednesday, December 06, 2023
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Thursday, November 30, 2023
BioCryst Pharmaceuticals Says It Will Receive...
Benzinga Newsdesk
CORRECTION: BioCryst Pharmaceuticals Ticker i...
Benzinga Newsdesk
BioCryst Pharmaceuticals Updated Its Agreemen...
Benzinga Newsdesk
Wednesday, November 29, 2023
BioCryst Reports Approval Of ORLADEYO (berotr...
Benzinga Newsdesk
Monday, November 20, 2023
Where BioCryst Pharma Stands With Analysts
Benzinga Insights
JP Morgan Reinstates Overweight on BioCryst P...
Benzinga Newsdesk
Friday, November 10, 2023
BioCryst Pharmaceuticals Releases New Real-wo...
Benzinga Newsdesk
Monday, November 06, 2023
Needham Reiterates Buy on BioCryst Pharma, Ma...
Benzinga Newsdesk
Friday, November 03, 2023
BioCryst R&D Day Highlights New Diversified P...
Benzinga Newsdesk
BioCryst And Clearside Biomedical Enter Partn...
Benzinga Newsdesk
Thursday, November 02, 2023
BioCryst Expects To Achieve No Less Than $320...
Benzinga Newsdesk
BioCryst Pharma Q3 Adjusted EPS $(0.19) Beats...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Friday, October 27, 2023
BioCryst Pharmaceuticals Says It Will Present...
Benzinga Newsdesk
Thursday, October 26, 2023
Biocryst Disclosed Enrollment Of The First Pa...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch